Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 185Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 8Nuedexta

PharmaCompass

01

Brand Name : Nuedexta

Dextromethorphan

arrow
Antibody Engineering
Not Confirmed

Brand Name : Nuedexta

arrow
Antibody Engineering
Not Confirmed

Dextromethorphan

Main Therapeutic Indication : CNS & Anesthesia

Currency : USD

2020 Revenue in Millions : 226

2019 Revenue in Millions : 251

Growth (%) : -10

blank

02

Brand Name : Nuedexta

Dextromethorphan

arrow
Antibody Engineering
Not Confirmed

Brand Name : Nuedexta

arrow
Antibody Engineering
Not Confirmed

Dextromethorphan

Main Therapeutic Indication : Neurology

Currency : USD

2021 Revenue in Millions : 216

2020 Revenue in Millions : 217

Growth (%) : 8

blank

03

Brand Name : Nuedexta

Dextromethorphan

arrow
Antibody Engineering
Not Confirmed

Brand Name : Nuedexta

arrow
Antibody Engineering
Not Confirmed

Dextromethorphan

Main Therapeutic Indication : Neurology

Currency : USD

2022 Revenue in Millions : 215

2021 Revenue in Millions : 216

Growth (%) : -1

blank

04

Brand Name : Nuedexta

Dextromethorphan

arrow
Antibody Engineering
Not Confirmed

Brand Name : Nuedexta

arrow
Antibody Engineering
Not Confirmed

Dextromethorphan

Main Therapeutic Indication : Neurology

Currency : USD

2023 Revenue in Millions : 196

2022 Revenue in Millions : 215

Growth (%) : 4

blank

05

Brand Name : Nuedexta

Dextromethorphan & Quinidine

arrow
Antibody Engineering
Not Confirmed

Brand Name : Nuedexta

arrow
Antibody Engineering
Not Confirmed

Dextromethorphan & Quinidine

Main Therapeutic Indication : Respiratory Disorders

Currency : USD

2016 Revenue in Millions : 216

2015 Revenue in Millions : 171

Growth (%) : 26

blank

06

Brand Name : Nuedexta

Dextromethorphan and Quinidine

arrow
Antibody Engineering
Not Confirmed

Brand Name : Nuedexta

arrow
Antibody Engineering
Not Confirmed

Dextromethorphan and Quinidine

Main Therapeutic Indication : Neurological/Mental Disorders

Currency : USD

2017 Revenue in Millions : 246

2016 Revenue in Millions : 227

Growth (%) : 8

blank

07

Brand Name : Nuedexta

Dextromethorphan and Quinidine

arrow
Antibody Engineering
Not Confirmed

Brand Name : Nuedexta

arrow
Antibody Engineering
Not Confirmed

Dextromethorphan and Quinidine

Main Therapeutic Indication : Neurological/Mental Disorders

Currency : USD

2018 Revenue in Millions : 230

2017 Revenue in Millions : 230

Growth (%) : -39%

blank

08

Brand Name : Nuedexta

Dextromethorphan

arrow
Antibody Engineering
Not Confirmed

Brand Name : Nuedexta

arrow
Antibody Engineering
Not Confirmed

Dextromethorphan

Main Therapeutic Indication : CNS & Anesthesia

Currency : USD

2019 Revenue in Millions : 246

2018 Revenue in Millions : 237

Growth (%) : 4

blank